**CVS Health’s upcoming November 4 earnings release for the third quarter of 2026 is the key near-term driver of trader positioning on the Q3 medical benefit ratio (MBR).** The Health Care Benefits segment posted an 87.4% MBR in Q2, down 250 basis points year-over-year, supported by stronger Medicare cost management, favorable prior-period development, and disciplined pricing, prompting an upward revision to full-year 2026 adjusted operating income guidance and an implied full-year MBR near 89.8% plus or minus 25 basis points. Market-implied odds remain tightly distributed across the 89–93.5%+ bins because Q3 results can vary with seasonal claims patterns, Medicaid and commercial trends, and any reserve adjustments. Traders are weighing the durability of the Aetna margin recovery against management’s prudent stance on second-half medical cost trends and potential volatility in government business performance.